You just read:

New Research Validates Translarna's™ (ataluren) Mechanism of Action to Promote Readthrough of Nonsense Mutations and Produce Full-length Functional Protein

News provided by

PTC Therapeutics, Inc.

Oct 04, 2016, 08:00 ET